Free Trial

Life Science REIT (LABS) Competitors

Life Science REIT logo
GBX 46 0.00 (0.00%)
As of 12:42 PM Eastern

LABS vs. THRL, IHR, MXF, AGR, PHP, PRSR, SHED, HWG, ESP, and MLI

Should you be buying Life Science REIT stock or one of its competitors? The main competitors of Life Science REIT include Target Healthcare REIT (THRL), Impact Healthcare REIT (IHR), Medicx Fund (MXF), Assura (AGR), Primary Health Properties (PHP), Prs Reit (PRSR), Urban Logistics REIT (SHED), Harworth Group (HWG), Empiric Student Property (ESP), and Industrials REIT (MLI). These companies are all part of the "real estate" sector.

Life Science REIT vs.

Target Healthcare REIT (LON:THRL) and Life Science REIT (LON:LABS) are both small-cap real estate companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, institutional ownership, risk, community ranking, dividends, media sentiment, valuation and earnings.

Target Healthcare REIT has a beta of 0.44, indicating that its stock price is 56% less volatile than the S&P 500. Comparatively, Life Science REIT has a beta of 0.08, indicating that its stock price is 92% less volatile than the S&P 500.

Target Healthcare REIT has a net margin of 104.99% compared to Life Science REIT's net margin of -198.99%. Target Healthcare REIT's return on equity of 10.78% beat Life Science REIT's return on equity.

Company Net Margins Return on Equity Return on Assets
Target Healthcare REIT104.99% 10.78% 3.86%
Life Science REIT -198.99%-14.53%1.25%

Life Science REIT has a consensus target price of GBX 46.50, indicating a potential upside of 1.09%. Given Life Science REIT's stronger consensus rating and higher probable upside, analysts clearly believe Life Science REIT is more favorable than Target Healthcare REIT.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Target Healthcare REIT
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Life Science REIT
0 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.67

Target Healthcare REIT has higher revenue and earnings than Life Science REIT. Life Science REIT is trading at a lower price-to-earnings ratio than Target Healthcare REIT, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Target Healthcare REIT£68.64M8.28£72.07M£11.937.78
Life Science REIT£20.41M8.00-£40.62M-£11.28-4.08

69.4% of Target Healthcare REIT shares are owned by institutional investors. Comparatively, 67.3% of Life Science REIT shares are owned by institutional investors. 0.1% of Target Healthcare REIT shares are owned by company insiders. Comparatively, 7.0% of Life Science REIT shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

In the previous week, Life Science REIT had 1 more articles in the media than Target Healthcare REIT. MarketBeat recorded 1 mentions for Life Science REIT and 0 mentions for Target Healthcare REIT. Target Healthcare REIT's average media sentiment score of 0.99 beat Life Science REIT's score of 0.30 indicating that Target Healthcare REIT is being referred to more favorably in the media.

Company Overall Sentiment
Target Healthcare REIT Positive
Life Science REIT Neutral

Target Healthcare REIT pays an annual dividend of GBX 6 per share and has a dividend yield of 6.5%. Life Science REIT pays an annual dividend of GBX 2 per share and has a dividend yield of 4.3%. Target Healthcare REIT pays out 50.3% of its earnings in the form of a dividend. Life Science REIT pays out -17.7% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

Target Healthcare REIT received 89 more outperform votes than Life Science REIT when rated by MarketBeat users. However, 80.00% of users gave Life Science REIT an outperform vote while only 65.03% of users gave Target Healthcare REIT an outperform vote.

CompanyUnderperformOutperform
Target Healthcare REITOutperform Votes
93
65.03%
Underperform Votes
50
34.97%
Life Science REITOutperform Votes
4
80.00%
Underperform Votes
1
20.00%

Summary

Target Healthcare REIT beats Life Science REIT on 13 of the 20 factors compared between the two stocks.

Remove Ads
Get Life Science REIT News Delivered to You Automatically

Sign up to receive the latest news and ratings for LABS and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

LABS vs. The Competition

MetricLife Science REITREIT IndustryReal Estate SectorLON Exchange
Market Cap£163.31M£1.55B£1.52B£2.61B
Dividend Yield5.67%7.52%6.67%4.95%
P/E Ratio-4.081.309.37152.60
Price / Sales8.00526.261,423.08282,666.96
Price / CashN/A49.2267.0627.91
Price / Book0.601.351.214.60
Net Income-£40.62M-£74.43M-£115.81M£5.77B
7 Day Performance5.75%1.02%0.42%-0.24%
1 Month Performance26.03%6.82%-0.81%4.16%
1 Year Performance6.73%9.63%5.34%133.37%

Life Science REIT Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
LABS
Life Science REIT
0.828 of 5 stars
GBX 46
flat
GBX 46.50
+1.1%
+5.5%£163.31M£20.41M-4.08N/AHigh Trading Volume
THRL
Target Healthcare REIT
N/AGBX 94.93
+0.8%
N/A+11.2%£581.09M£68.64M7.96N/A
IHR
Impact Healthcare REIT
N/AN/AGBX 114
+∞
N/A£361.75M£53.51M793.64N/APositive News
MXF
Medicx Fund
N/AN/AN/AN/A£0.00N/A0.00N/AHigh Trading Volume
AGR
Assura
1.1918 of 5 stars
GBX 46.98
+0.2%
GBX 49.50
+5.4%
+11.7%£1.53B£188.76M-44.9184
PHP
Primary Health Properties
2.3584 of 5 stars
GBX 95.50
-0.3%
GBX 107.50
+12.6%
+0.1%£1.28B£178.59M-149.0758Gap Down
PRSR
Prs Reit
1.9502 of 5 stars
GBX 113.80
+0.2%
GBX 120
+5.4%
+43.5%£622.84M£58.11M6.652News Coverage
SHED
Urban Logistics REIT
1.0584 of 5 stars
GBX 131.17
+0.1%
GBX 142
+8.3%
+8.8%£608.82M£58.96M24.97N/A
HWG
Harworth Group
N/AGBX 169.45
-1.5%
N/A+23.9%£557.86M£97.22M11.17120Earnings Report
Dividend Increase
Positive News
ESP
Empiric Student Property
N/AGBX 81.49
-0.1%
N/A-14.1%£539.82M£89.58M9.15150News Coverage
MLI
Industrials REIT
N/AN/AN/AN/A£494.79M£50.19M1,050.005,140
Remove Ads

Related Companies and Tools


This page (LON:LABS) was last updated on 3/25/2025 by MarketBeat.com Staff
From Our Partners